JW Pharmaceutical
↗Gwacheon, South Korea
JW Pharmaceutical is a leading South Korean pharmaceutical company founded in 1945. It is a pioneer in the Korean hospital market, particularly known for its dominance in the IV fluid (infusion) segment and its 'Respect for Life' philosophy. The company has evolved from a manufacturer of essential medicines into an R&D-driven global player focusing on first-in-class innovative drugs.
The company operates under the JW Group (JW Holdings) and has established a robust global R&D network, including C&C Research Laboratories (a joint venture with Chugai Pharmaceutical) and JW Theriac in the U.S. Its core research focuses on the Wnt and STAT signaling pathways, targeting oncology, immunology, and regenerative medicine. JW Pharmaceutical is also a major distributor of global blockbuster drugs in Korea, such as Roche's Hemlibra and Livalo (Pitavastatin).
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty & Generic Drug Manufacturing
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$500M-$600M
Founded:1945
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:JW Holdings, National Pension Service of Korea
STOCK
Exchange:KRX
Ticker:001060
Market Cap:$544M
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 3
Modalities:Small molecule, IV Solutions, mAbs
Active Trials:12
Trial Phases:Phase 1: 4 | Phase 2: 3 | Phase 3: 2 | Phase 4: 3
FDA Approvals:0
EMA Approvals:1
CORPORATE STRUCTURE
Parent Company:JW Holdings
Subsidiaries:JW Medical, JW Life Science, JW Shinyak, C&C Research Laboratories, Euvipharm (Vietnam)
Key Partnerships:Leo Pharma (Atopic Dermatitis licensing), Roche/Chugai (Hemlibra and R&D collaboration), Kissei Pharmaceutical (Fostamatinib licensing), Tempus AI (Precision oncology data collaboration)
COMPETITION
Position:Leader
Competitors:Hanmi Pharmaceutical, Yuhan Corporation, GC Biopharma, Daewoong Pharmaceutical
LEADERSHIP
Key Executives:
Lee Kyung-ha - Chairman
Shin Young-seop - Co-CEO
Ham Eun-kyung - Co-CEO
Scientific Founders:Lee Gi-seok
Board Members:Lee Kyung-ha, Shin Young-seop, Ham Eun-kyung, Cha Seong-nam
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with JW Pharmaceutical. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.